City

Bethesda (1)

Leuven (1)

Condition

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (3)

Acute Myeloid Leukaemia (AML) (1)

Myelodysplastic Syndrome (MDS) (1)

Overall Status

Not yet recruiting (2)

Unknown status (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

National Heart, Lung, and Blood Institute (NHLBI) (1)

Universitaire Ziekenhuizen Leuven (1)

medac GmbH (1)

Collaborator

National Institutes of Health Clinical Center (CC) (1)

Synteract, Inc. (1)

Intervention

blood sampling (1)

fludarabine (1)

treosulfan (1)

Study Documents

Intervention Type

drug (1)

procedure (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Observational (2)

Interventional (1)

allogeneic hematopoietic stem cell transplantation (hsct)

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Infectious and Noninfectious Lung Diseases Following Allogeneic

Not yet recruiting

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Bethesda, Maryland

National Institutes of Health Clinical Center

Oct 27, 2023

Acute Myeloid Leukaemia (AML), Myelodysplastic Syndrome (MDS), Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Trial

Not yet recruiting

Acute Myeloid Leukaemia (AML)
+2 more

(no location specified)

Sep 6, 2022

Posaconazole in Allogeneic Transplant Patients With Mucositis

Unknown status

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

blood sampling

Leuven, Vlaams-Brabant, Belgium

University Hospitals Leuven

Jan 13, 2015